Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized-controlled Trial to Assess the Safety and Efficacy of Intravascular Hypothermia in Acute Ischemia Stroke Patients With Recanalization After Thrombectomy

NCT05676957 is registered in ClinicalTrials.gov with Liping Liu as lead sponsor.

NCT NCT05676957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05676957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized-controlled Trial to Assess the Safety and Efficacy of Intravascular Hypothermia in Acute Ischemia Stroke Patients With Recanalization After Thrombectomy
Lead sponsor
Liping Liu
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2023
Completion date
March 1, 2024
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endovascular treatment, ischemic stroke, reperfusion injury, revascularization